Massive bone marrow infiltration of neuroendocrine carcinoma mimicking aggressive hematological malignancy
Satoshi Ichikawa(Tohoku University), Hideo Harigae(Tohoku University Hospital), Yoshifumi Kawamura(Tohoku University), Noriko Fukuhara(Tohoku University Hospital), Kota Ouchi(Tohoku University), Kyoko Inokura(Tohoku University Hospital), Hisayuki Yokoyama(Sendai Medical Center), Fumiyoshi Fujishima(Tohoku University Hospital)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
|Nature|2011|388
MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
|The EMBO Journal|2014|302